About PanTHERA CryoSolutions
PanTHERA CryoSolutions is a Healthcare company based in Edmonton (Canada) founded in 2018 by Jason Acker and Robert Ben, and was acquired by BioLife Solutions in April 2025. It operates as a cryopreservation platform for cells, tissues, and organs is provided. PanTHERA CryoSolutions has raised $6 million across 2 funding rounds from investors including BioLife Solutions and Casdin Capital. PanTHERA CryoSolutions offers products and services including Ice Recrystallization Inhibitors. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Preservation. Its competitors include Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions and 5 more; 6 of its 10 listed competitors have raised funding.
Company details
PanTHERA CryoSolutions was founded in 2018 in Edmonton, Canada, within the biotechnology sector. Technology for cryopreserving cells, tissues, and organs is offered through a patented small molecule ice crystal inhibitor (IRI). Cellular function is preserved during prolonged frozen storage, with reductions in toxicity, stress, and ice crystal development. Dependence on DMSO, liquid nitrogen, and sample thawing is decreased in biological applications.
- Headquarters Edmonton, Canada
- Founders Jason Acker, Robert Ben
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website pantheracryo.com
- Social LinkedIn X Facebook YouTube
- Acquired by BioLife Solutions (Apr 2025)
- Total Equity Funding$6M (USD)
in 2 rounds
- Latest Funding Round$4M (USD), Series A
Jan 2021
- InvestorsBioLife Solutions
& 1 more
- Acquired byBioLife Solutions
(Apr 2025)
Products & Services of PanTHERA CryoSolutions
PanTHERA CryoSolutions offers a comprehensive portfolio of products and services, including Ice Recrystallization Inhibitors.
Products that reduce ice damage and improve cell recovery in freezing processes.
Apps and channels of PanTHERA CryoSolutions
its YouTube channel PanTHERA CryoSolutions has 1 subscribers.
Funding Insights of PanTHERA CryoSolutions
PanTHERA CryoSolutions has successfully raised a total of $6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6M
- Total Rounds 2
- Last Round Series A — $4M
- First Round $2M
(Dec 2020)
- Investors Count 2
All 2 funding rounds of PanTHERA CryoSolutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $4M | Series A | – | Casdin Capital, BioLife Solutions | – |
| Dec 2020 | $2M | Seed | – | Casdin Capital, BioLife Solutions | – |
2 investors in total: 2 institutional.
Investors in PanTHERA CryoSolutions
PanTHERA CryoSolutions has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include BioLife Solutions and Casdin Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investing in Life Sciences sectors like Healthcare and Biotechnology. | – | casdincapital.com | - | |
Tissue hypothermic storage and cryopreservation freeze media are developed. | 1987 | biolifesolutions.com | Bothell, United States |
Investor details for PanTHERA CryoSolutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PanTHERA CryoSolutions
8 people are tracked at PanTHERA CryoSolutions (2 in leadership, 3 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Jason Acker | Co-Founder | Leadership |
Robert Ben | Co-Founder | Leadership |
Peter Lee | Board Member | Board & advisors |
Aby Mathew | Board Member | Board & advisors |
Erik Woods | Board Member | Board & advisors |
Ilias Mahmud | Senior R&D Synthetic Organic Chemist | Team |
Jasper Quartus | Synthetic Organic Chemist | Team |
Odile Pressoir | Organic Chemist | Team |
Complete people profiles for PanTHERA CryoSolutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PanTHERA CryoSolutions
4 dated milestones of PanTHERA CryoSolutions across 7 years, from founding to its latest funding, stage changes and deals.
- Founded PanTHERA CryoSolutions is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series A, of $4.0M.
- Exit Acquired by BioLife Solutions.
Competitors of PanTHERA CryoSolutions
PanTHERA CryoSolutions has 10 listed competitors in our database, 6 of them funded. They include Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| brooks.com | 1978 | Chelmsford, United States | – | 1,928 | Vacuum robots for semiconductor wafer handling are developed. | |
| bridgetolife.com | 2012 | Columbia, United States | $57M | – | Cold storage solutions for organ transplant preservation are provided. | |
| hemanext.com | 2004 | Lexington, United States | $127.57M | 53 | Technologies for blood and product storage are developed. | |
| atelerix.co.uk | 2017 | Newcastle Upon Tyne, United Kingdom | $2.43M | 9 | Technology for cell storage and transportation is developed. | |
| cellbox-solutions.com | 2016 | Lubeck, Germany | $6.99M | – | Portable devices for cell storage and transport are provided. | |
| coldchaintech.com | 2001 | Franklin, United States | – | – | Thermal packaging solutions and cold chain monitoring services are provided. | |
| nectome.com | 2015 | San Francisco, United States | – | – | Brain preservation is achieved through chemical fixation and vitrification techniques. | |
| biocision.com | 2007 | Larkspur, United States | $11.1M | 48 | Provider of handling, storage and transport solutions for temperature-sensitive biomedical samples and drugs | |
| genepoint.cn | 2015 | Shanghai, China | $48.3M | – | Platform for cryostorage and long-term biological preservation is provided. | |
| preanalytix.com | 2000 | Hombrechtikon, Switzerland | – | – | Sample collection and storage systems for biomolecules are provided. |
Detailed competitors of PanTHERA CryoSolutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PanTHERA CryoSolutions
The website of PanTHERA CryoSolutions (pantheracryo.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 19.6% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as PanTHERA CryoSolutions (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Panthera Cryosolutions
Complete news archive for PanTHERA CryoSolutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PanTHERA CryoSolutions
PanTHERA CryoSolutions was founded in 2018 and raised its 1st funding round 2 years after it was founded.
PanTHERA CryoSolutions is headquartered in Edmonton, Canada. It is registered at Edmonton, Alberta, Canada.
PanTHERA CryoSolutions is a funded company, having raised a total of $6M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Dec 2020.
PanTHERA CryoSolutions was founded in 2018 in Edmonton, Canada, within the biotechnology sector. Technology for cryopreserving cells, tissues, and organs is offered through a patented small molecule ice crystal inhibitor (IRI). Cellular function is preserved during prolonged frozen storage, with reductions in toxicity, stress, and ice crystal development. Dependence on DMSO, liquid nitrogen, and sample thawing is decreased in biological applications.
PanTHERA CryoSolutions's top competitors include Brooks Automation, Hemanext and Bridge to Life.
PanTHERA CryoSolutions offers Ice Recrystallization Inhibitors.
PanTHERA CryoSolutions has 2 investors. Key investors include BioLife Solutions, and Casdin Capital.
Yes. PanTHERA CryoSolutions was acquired by BioLife Solutions in April 2025.